Home
Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 24/03/19
Trade details
- Type
- Insider sale
- Amount
- $1,557,676.35
- Shares · price
- 6,627 sh · $235.05 a share
- Held after
- 284 sh
- Trade date
- 24/03/18
- Filed
- 24/03/19
- Days to filing
- 1 days
Sold 95.9% of holdings
- Share of holding sold
- 95.9%
United Therapeutics trades, last 26 weeks
What else happened in United Therapeutics around then
Filed or reported within 30 days of the trade day · 24/02/17~24/04/17Martine A. Rothblatt's recent trades
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$220.2K
400 sh
$220.2K
Filed 10/01
Traded 09/30
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$218.9K
400 sh
$218.9K
Filed 10/01
Traded 09/30
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$153.5K
280 sh
$153.5K
Filed 10/01
Traded 09/30
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$131.9K
240 sh
$131.9K
Filed 10/01
Traded 09/30
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$114.8K
207 sh
$114.8K
Filed 10/01
Traded 09/30